Half-year report · Q2
7133.TEDINET S100UP3P
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥8.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | ¥449m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥717m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥6.9bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥5.0bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥889m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥688m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥889m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥688m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥707m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥539m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥41.03 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.05 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.62 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.26 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 19
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥296m |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥277m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥338m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥134m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥749m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥745m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 331
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounts payable trade | CurrentQuarterInstant | 844478000 | JPY |
| Short term loans payable | Prior1YearInstant | 200000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 450000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 256935000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 256106000 | JPY |
| Income taxes payable | Prior1YearInstant | 180707000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 167208000 | JPY |
| Provision for bonuses | Prior1YearInstant | 100672000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 56884000 | JPY |
| Other cl | Prior1YearInstant | 529499000 | JPY |
| Other cl | CurrentQuarterInstant | 503151000 | JPY |
| Current liabilities | Prior1YearInstant | 2019593000 | JPY |
| Current liabilities | CurrentQuarterInstant | 2277829000 | JPY |
| Long term loans payable | Prior1YearInstant | 2173064000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 2141686000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 85674000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 87647000 | JPY |
| Other ncl | Prior1YearInstant | 433539000 | JPY |
| Other ncl | CurrentQuarterInstant | 458100000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 2692277000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 2687434000 | JPY |
| Liabilities | Prior1YearInstant | 4711871000 | JPY |
| Liabilities | CurrentQuarterInstant | 4965263000 | JPY |
| Capital stock | Prior1YearInstant | 195382000 | JPY |
| Capital stock | CurrentQuarterInstant | 195588000 | JPY |
| Capital surplus | Prior1YearInstant | 345392000 | JPY |
| Capital surplus | CurrentQuarterInstant | 345598000 | JPY |
| Retained earnings | Prior1YearInstant | 1402327000 | JPY |
| Retained earnings | CurrentQuarterInstant | 1693656000 | JPY |
| Treasury stock | Prior1YearInstant | -299978000 | JPY |
| Treasury stock | CurrentQuarterInstant | -299978000 | JPY |
| Shareholders equity | Prior1YearInstant | 1643125000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 1934866000 | JPY |
| Net assets | Prior1YearInstant | 1643125000 | JPY |
| Net assets | CurrentQuarterInstant | 1934866000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 6354996000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 6900129000 | JPY |
| Net sales | CurrentYTDDuration | 4719387000 | JPY |
| Cost of sales | CurrentYTDDuration | 3624629000 | JPY |
| Gross profit | CurrentYTDDuration | 1094758000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 646220000 | JPY |
| Operating income | CurrentYTDDuration | 448537000 | JPY |
| Interest income noi | CurrentYTDDuration | 1751000 | JPY |
| Subsidy income noi | CurrentYTDDuration | 2689000 | JPY |
| Other noi | CurrentYTDDuration | 107000 | JPY |
| Non operating income | CurrentYTDDuration | 4547000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 17904000 | JPY |
| Other noe | CurrentYTDDuration | 43000 | JPY |
| Non operating expenses | CurrentYTDDuration | 17948000 | JPY |
| Ordinary income | CurrentYTDDuration | 435136000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |